Hutch News
Results per Page:
Pretargeting redux: A bispecific antibody re-ignites radioimmunotherapy
From the Green lab, Clinical Research Division
One family, two sides of cancer
Basic scientist Dr. Wenying Shou’s parents were both treated for — and cured of — their cancers. The similarities end there.
Mourning the loss of Dr. Oliver 'Ollie' Press
Lymphoma physician-scientist, leader and mentor made lifesaving contributions to the development of targeted cancer therapies
Good News: American Society of Hematology to recognize Dr. Oliver Press for outstanding mentorship
American Society of Hematology to recognize Dr. Oliver Press for outstanding mentorship
‘He transformed my life’: A cancer doctor’s work comes full circle
The impact of Dr. Oliver Press, pioneering researcher, beloved physician and influential mentor
Good News: Dr. Glenda Gray among Time magazine’s ‘100 most influential’
Celebrating faculty and staff achievements
Good News: Damian Green awarded $3.2M to test radioimmunotherapy for multiple myeloma ... and more
Celebrating faculty and staff achievements
Applicants wanted: Most inclusive fellowship program among top cancer centers
New fellowships created to support scientists from underrepresented groups, attract more top minds to Fred Hutch
Lymphoma Research Foundation Announces Over $1 Million in Research Grants
Fred Hutchinson Cancer Research Center Researcher Receives Top Grant Award to Pursue New Treatments and Cures for Lymphoma